Skip to main content
. 2022 Jan 19;60(1):e02919-20. doi: 10.1128/JCM.02919-20

FIG 2.

FIG 2

Bedaquiline 7H9 broth microdilution MIC distribution for MDR-TB clinical isolates. Susceptible (S), area of technical uncertainty (ATU)/intermediate (I), and resistant (R) breakpoints are indicated by arrows.